NYSE LISTED TEST STOCK FOR CTS AND CQS
NYSE LISTED TEST STOCK FOR CTS AND CQS
NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) - Total Assets
Latest total assets as of June 2021: $7.10 Billion USD
Based on the latest financial reports, NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) holds total assets worth $7.10 Billion USD as of June 2021.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NYSE LISTED TEST STOCK FOR CTS AND CQS - Total Assets Trend (2019–2020)
This chart illustrates how NYSE LISTED TEST STOCK FOR CTS AND CQS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NYSE LISTED TEST STOCK FOR CTS AND CQS - Asset Composition Analysis
Current Asset Composition (December 2020)
NYSE LISTED TEST STOCK FOR CTS AND CQS's total assets of $7.10 Billion consist of 24.0% current assets and 76.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.8% |
| Accounts Receivable | $390.40 Million | 6.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.73 Billion | 26.5% |
| Goodwill | $2.90 Billion | 44.4% |
Asset Composition Trend (2019–2020)
This chart illustrates how NYSE LISTED TEST STOCK FOR CTS AND CQS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NYSE LISTED TEST STOCK FOR CTS AND CQS's current assets represent 24.0% of total assets in 2020, an increase from 11.9% in 2019.
- Cash Position: Cash and equivalents constituted 3.8% of total assets in 2020, down from 4.5% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 70.0% of total assets, a decrease from 83.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 44.4% of total assets.
NYSE LISTED TEST STOCK FOR CTS AND CQS Competitors by Total Assets
Key competitors of NYSE LISTED TEST STOCK FOR CTS AND CQS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
NYSE LISTED TEST STOCK FOR CTS AND CQS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - NYSE LISTED TEST STOCK FOR CTS AND CQS generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - NYSE LISTED TEST STOCK FOR CTS AND CQS is currently not profitable relative to its asset base.
NYSE LISTED TEST STOCK FOR CTS AND CQS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.36 | 1.57 | 2.16 |
| Quick Ratio | 1.36 | 1.57 | 2.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $576.80 Million | $ 284.70 Million | $ 326.00 Million |
NYSE LISTED TEST STOCK FOR CTS AND CQS - Advanced Valuation Insights
This section examines the relationship between NYSE LISTED TEST STOCK FOR CTS AND CQS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 27.4% |
| Total Assets | $6.52 Billion |
| Market Capitalization | $237.68K USD |
Valuation Analysis
Below Book Valuation: The market values NYSE LISTED TEST STOCK FOR CTS AND CQS's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: NYSE LISTED TEST STOCK FOR CTS AND CQS's assets grew by 27.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for NYSE LISTED TEST STOCK FOR CTS AND CQS (2019–2020)
The table below shows the annual total assets of NYSE LISTED TEST STOCK FOR CTS AND CQS from 2019 to 2020.
| Year | Total Assets | Change |
|---|---|---|
| 2020-12-31 | $6.52 Billion | +27.43% |
| 2019-12-31 | $5.11 Billion | -- |